rank	score	disease_name	disease_identifier
1	1.0	Spongiform encephalopathy with neuropsychiatric features	OMIM:606688
2	0.9786	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	OMIM:221770
3	0.9783	Gerstmann-Straussler disease	OMIM:137440
4	0.9712	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	OMIM:600795
5	0.9701	CLN3 disease	ORPHA:228346
6	0.9601	Spastic paraplegia 4, autosomal dominant	OMIM:182601
7	0.9568	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	OMIM:125310
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
8	0.9542	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
15	0.9535	Autosomal recessive spastic paraplegia type 11	ORPHA:2822
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
16	0.9496	MELAS	ORPHA:550
23	0.9474	Fragile X tremor/ataxia syndrome	OMIM:300623
24	0.9426	Nasu-Hakola disease	ORPHA:2770
24	0.9426	Nasu-Hakola disease	ORPHA:2770
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
26	0.9414	Progressive non-fluent aphasia	ORPHA:100070
34	0.9399	Landau-Kleffner syndrome	ORPHA:98818
35	0.936	Fragile X-associated tremor/ataxia syndrome	ORPHA:93256
35	0.936	Neuropathy, hereditary sensory, type IE	OMIM:614116
35	0.936	Basal ganglia calcification, idiopathic, 5	OMIM:615483
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
38	0.9324	Behavioral variant of frontotemporal dementia	ORPHA:275864
47	0.93	Supranuclear palsy, progressive	OMIM:601104
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
48	0.9298	Cushing disease	ORPHA:96253
55	0.9297	Acute intermittent porphyria	ORPHA:79276
56	0.9279	Aphasia, primary progressive	OMIM:607485
57	0.9248	Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy	ORPHA:136
58	0.9223	Creutzfeldt-Jakob disease	OMIM:123400
58	0.9223	Creutzfeldt-Jakob disease, variant, resistance to	OMIM:123400
60	0.9195	?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8	OMIM:619132
61	0.9192	Huntington disease-like 2	OMIM:606438
62	0.919	Progressive supranuclear palsy-parkinsonism syndrome	ORPHA:240085
63	0.9156	Huntington disease	ORPHA:399
63	0.9156	Huntington disease	ORPHA:399
65	0.9131	Sneddon syndrome	ORPHA:820
65	0.9131	Methylmalonic acidemia with homocystinuria, type cblC	ORPHA:79282
67	0.9088	Huntington disease-like 1	ORPHA:157941
67	0.9088	ABeta amyloidosis, Iowa type	ORPHA:324708
67	0.9088	Alzheimer disease, type 3, with spastic paraparesis and apraxia	OMIM:607822
67	0.9088	Alzheimer disease-4	OMIM:606889
67	0.9088	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	OMIM:618193
67	0.9088	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	OMIM:604121
67	0.9088	Huntington disease-like 2	ORPHA:98934
67	0.9088	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
67	0.9088	?Alzheimer disease, protection against, due to APOE3-Christchurch	OMIM:607822
67	0.9088	Dentatorubral pallidoluysian atrophy	ORPHA:101
67	0.9088	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
67	0.9088	Basal ganglia calcification, idiopathic, 6	OMIM:616413
79	0.9061	Leukoencephalopathy, diffuse hereditary, with spheroids 1	OMIM:221820
80	0.9058	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly	OMIM:619827
81	0.9028	Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations	ORPHA:247691
82	0.9025	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
82	0.9025	Urbach-Wiethe disease	OMIM:247100
82	0.9025	Spinocerebellar ataxia type 27	ORPHA:98764
82	0.9025	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
86	0.9004	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	OMIM:619133
87	0.8899	Citrullinemia type II	ORPHA:247585
88	0.8851	Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome	ORPHA:314404
88	0.8851	X-linked cerebral adrenoleukodystrophy	ORPHA:139396
88	0.8851	Congenital bile acid synthesis defect type 4	ORPHA:79095
88	0.8851	Basal ganglia calcification, idiopathic, 7, autosomal recessive	OMIM:618317
88	0.8851	Spinocerebellar ataxia 14	OMIM:605361
88	0.8851	Basal ganglia calcification, idiopathic, 1	OMIM:213600
94	0.8796	15q11.2 microdeletion syndrome	ORPHA:261183
94	0.8796	15q11.2 microdeletion syndrome	ORPHA:261183
94	0.8796	15q11.2 microdeletion syndrome	ORPHA:261183
97	0.8793	Inherited Creutzfeldt-Jakob disease	ORPHA:282166
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
98	0.8762	Meningioma	ORPHA:2495
109	0.8757	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	OMIM:192315
110	0.8697	Spinocerebellar ataxia 17	OMIM:607136
111	0.8633	Spastic paraplegia 78, autosomal recessive	OMIM:617225
112	0.8557	Kufor-Rakeb syndrome	OMIM:606693
112	0.8557	Norrie disease	OMIM:310600
112	0.8557	Beta-propeller protein-associated neurodegeneration	ORPHA:329284
115	0.8534	Neurodegeneration with brain iron accumulation 5	OMIM:300894
116	0.8506	Autosomal dominant Charcot-Marie-Tooth disease type 2Y	ORPHA:435387
116	0.8506	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
116	0.8506	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure	OMIM:603896
116	0.8506	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
120	0.8476	Spinocerebellar ataxia type 1	ORPHA:98755
120	0.8476	Aceruloplasminemia	ORPHA:48818
122	0.8454	Huntington disease-like 1	OMIM:603218
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
123	0.842	Behçet disease	ORPHA:117
136	0.8414	Parkinson disease 14, autosomal recessive	OMIM:612953
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
137	0.8394	Lynch syndrome	ORPHA:144
148	0.8374	Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy	ORPHA:199354
149	0.8329	Choreoacanthocytosis	OMIM:200150
150	0.8308	Dementia, frontotemporal	OMIM:600274
150	0.8308	Dementia, frontotemporal, with or without parkinsonism	OMIM:600274
152	0.8293	CNTNAP2-related developmental and epileptic encephalopathy	ORPHA:163681
153	0.829	3-methylglutaconic aciduria, type I	OMIM:250950
154	0.8265	Neurodegeneration with brain iron accumulation 3	OMIM:606159
155	0.8239	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	OMIM:105550
156	0.8201	Neurodegeneration with brain iron accumulation 4	OMIM:614298
156	0.8201	Ceroid lipofuscinosis, neuronal, 13 (Kufs type)	OMIM:615362
156	0.8201	Lafora disease	ORPHA:501
156	0.8201	Lafora disease	ORPHA:501
160	0.8179	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
160	0.8179	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
160	0.8179	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
160	0.8179	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
164	0.8175	Kufor-Rakeb syndrome	ORPHA:306674
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
165	0.8171	Lennox-Gastaut syndrome	ORPHA:2382
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
172	0.817	Hereditary late-onset Parkinson disease	ORPHA:411602
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
179	0.8162	Young-onset Parkinson disease	ORPHA:2828
190	0.8157	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
190	0.8157	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
192	0.8145	GM2-gangliosidosis, several forms	OMIM:272800
193	0.8131	Choreoacanthocytosis	ORPHA:2388
194	0.813	Spinocerebellar ataxia, autosomal recessive 27	OMIM:618369
194	0.813	Spinocerebellar ataxia 21	OMIM:607454
196	0.812	Kleine-Levin syndrome	ORPHA:33543
197	0.8107	CLN5 disease	ORPHA:228360
198	0.8098	Ceroid lipofuscinosis, neuronal, 3	OMIM:204200
199	0.8097	Continuous spikes and waves during sleep	ORPHA:725
199	0.8097	Continuous spikes and waves during sleep	ORPHA:725
199	0.8097	Mucopolysaccharidosis type IIIB (Sanfilippo B)	OMIM:252920
202	0.8085	Rubinstein-Taybi syndrome due to CREBBP mutations	ORPHA:353277
202	0.8085	Rubinstein-Taybi syndrome due to 16p13.3 microdeletion	ORPHA:353281
202	0.8085	Rubinstein-Taybi syndrome due to EP300 haploinsufficiency	ORPHA:353284
205	0.8081	Alternating hemiplegia of childhood	ORPHA:2131
205	0.8081	Alternating hemiplegia of childhood	ORPHA:2131
205	0.8081	Alternating hemiplegia of childhood	ORPHA:2131
205	0.8081	Alternating hemiplegia of childhood	ORPHA:2131
209	0.8068	HSD10 mitochondrial disease	OMIM:300438
210	0.8039	Wiedemann-Steiner syndrome	ORPHA:319182
211	0.8038	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	OMIM:607459
212	0.8031	Pitt-Hopkins like syndrome 1	OMIM:610042
213	0.8024	Cerebrotendinous xanthomatosis	ORPHA:909
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Semantic dementia	ORPHA:100069
214	0.8008	Perry syndrome	ORPHA:178509
214	0.8008	GM2-gangliosidosis, AB variant	OMIM:272750
214	0.8008	Mast syndrome	OMIM:248900
224	0.7996	Neuroferritinopathy	ORPHA:157846
225	0.7952	Juvenile Huntington disease	ORPHA:248111
225	0.7952	CARASIL syndrome	OMIM:600142
225	0.7952	Parkinson disease 6, early onset	OMIM:605909
225	0.7952	Pyruvate dehydrogenase E2 deficiency	ORPHA:79244
225	0.7952	NARP syndrome	ORPHA:644
225	0.7952	Chorea, hereditary benign	OMIM:118700
225	0.7952	Spinocerebellar ataxia 12	OMIM:604326
225	0.7952	Amyloidosis, hereditary, transthyretin-related	OMIM:105210
225	0.7952	Wolfram-like syndrome	ORPHA:411590
225	0.7952	Childhood-onset benign chorea with striatal involvement	ORPHA:494541
235	0.7821	Pick disease	OMIM:172700
235	0.7821	Pick disease	OMIM:172700
237	0.7794	Perry syndrome	OMIM:168605
238	0.7776	Frontotemporal lobar degeneration, TARDBP-related	OMIM:612069
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	OMIM:616437
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
239	0.7725	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	OMIM:616439
239	0.7725	Frontotemporal dementia with motor neuron disease	ORPHA:275872
248	0.7704	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities	OMIM:620330
249	0.7642	Alzheimer disease 9, susceptibility to	OMIM:608907
249	0.7642	Adrenomyeloneuropathy	ORPHA:139399
249	0.7642	Full NF2-related schwannomatosis	ORPHA:637
249	0.7642	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
249	0.7642	Developmental delay, impaired speech, and behavioral abnormalities	OMIM:619475
249	0.7642	Combined malonic and methylmalonic acidemia	ORPHA:289504
249	0.7642	Spinocerebellar ataxia type 28	ORPHA:101109
249	0.7642	Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure	OMIM:620312
249	0.7642	Sialuria	ORPHA:3166
249	0.7642	Epilepsy, progressive myoclonic 6	OMIM:614018
249	0.7642	Waldenström macroglobulinemia	ORPHA:33226
249	0.7642	17q11 microdeletion syndrome	ORPHA:97685
249	0.7642	Spinocerebellar ataxia 50	OMIM:620158
249	0.7642	Combined oxidative phosphorylation deficiency 54	OMIM:619737
249	0.7642	Autosomal spastic paraplegia type 72	ORPHA:401849
249	0.7642	Epilepsy, progressive myoclonic 6	OMIM:614018
249	0.7642	Spastic paraplegia type 7	ORPHA:99013
249	0.7642	Spastic paraplegia 7, autosomal recessive	OMIM:607259
249	0.7642	Autosomal recessive cerebellar ataxia due to STUB1 deficiency	ORPHA:412057
249	0.7642	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
249	0.7642	Crigler-Najjar syndrome type 1	ORPHA:79234
249	0.7642	Spastic ataxia 1, autosomal dominant	OMIM:108600
249	0.7642	Autosomal dominant spastic ataxia type 1	ORPHA:251282
272	0.7591	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	OMIM:167320
272	0.7591	Autosomal recessive spastic paraplegia type 15	ORPHA:100996
274	0.7542	O'Donnell-Luria-Rodan syndrome	OMIM:618512
275	0.7514	Gerstmann-Straussler-Scheinker syndrome	ORPHA:356
275	0.7514	ABeta amyloidosis, Dutch type	ORPHA:100006
275	0.7514	ABeta amyloidosis, Italian type	ORPHA:324713
275	0.7514	Adrenoleukodystrophy	OMIM:300100
275	0.7514	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	OMIM:616779
275	0.7514	Parkinson disease 1	OMIM:168601
275	0.7514	Parkinson disease 23, autosomal recessive, early onset	OMIM:616840
275	0.7514	Autosomal recessive spastic paraplegia type 21	ORPHA:101001
275	0.7514	?Leukoencephalopathy, hereditary diffuse, with spheroids 2	OMIM:619661
275	0.7514	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	OMIM:208920
275	0.7514	Ceroid lipofuscinosis, neuronal, 6B (Kufs type)	OMIM:204300
275	0.7514	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	OMIM:254800
275	0.7514	Spastic paraplegia 46, autosomal recessive	OMIM:614409
275	0.7514	Ichthyosis follicularis-alopecia-photophobia syndrome	ORPHA:2273
275	0.7514	Neurodegeneration with brain iron accumulation 1	OMIM:234200
275	0.7514	Amelocerebrohypohidrotic syndrome	ORPHA:1946
275	0.7514	Amelocerebrohypohidrotic syndrome	ORPHA:1946
275	0.7514	Mohr-Tranebjaerg syndrome	ORPHA:52368
293	0.7501	Parenti-Mignot neurodevelopmental syndrome	OMIM:619873
293	0.7501	Intellectual developmental disorder, autosomal dominant 38	OMIM:616393
295	0.7477	Epilepsy, progressive myoclonic 2A (Lafora)	OMIM:254780
295	0.7477	Epilepsy, progressive myoclonic 2B (Lafora)	OMIM:254780
295	0.7477	Gaucher disease, type III	OMIM:231000
295	0.7477	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
295	0.7477	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
295	0.7477	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
295	0.7477	Epilepsy, progressive myoclonic, 8	OMIM:616230
295	0.7477	Progressive epilepsy-intellectual disability syndrome, Finnish type	ORPHA:1947
295	0.7477	Dementia, familial British	OMIM:176500
304	0.747	Adenylosuccinase deficiency	OMIM:103050
305	0.7464	Intellectual developmental disorder, X-linked syndromic, Bain type	OMIM:300986
306	0.7458	Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome	ORPHA:457212
306	0.7458	Intellectual developmental disorder, autosomal recessive 48	OMIM:616269
308	0.7456	X-linked intellectual disability-psychosis-macroorchidism syndrome	ORPHA:3077
309	0.7445	Progressive myoclonic epilepsy type 3	ORPHA:263516
310	0.7441	Intellectual developmental disorder, autosomal dominant 1	OMIM:156200
311	0.7422	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	OMIM:619580
312	0.7421	Symptomatic form of fragile X syndrome in female carriers	ORPHA:449291
312	0.7421	White-Sutton syndrome	OMIM:616364
314	0.741	Pitt-Hopkins syndrome	ORPHA:2896
315	0.7409	Infantile neuroaxonal dystrophy	ORPHA:35069
316	0.7408	Phenylketonuria	OMIM:261600
317	0.7396	Brunner syndrome	OMIM:300615
317	0.7396	Antisocial behavior	OMIM:300615
319	0.7384	Pelizaeus-Merzbacher disease	OMIM:312080
319	0.7384	Intellectual developmental disorder, autosomal recessive 46	OMIM:616116
321	0.738	SATB2-associated syndrome due to a chromosomal rearrangement	ORPHA:251028
322	0.736	Succinic semialdehyde dehydrogenase deficiency	OMIM:271980
322	0.736	Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies	OMIM:619031
322	0.736	Usmani-Riazuddin syndrome, autosomal dominant	OMIM:619467
322	0.736	Chilton-Okur-Chung neurodevelopmental syndrome	OMIM:619841
322	0.736	CLCN4-related X-linked intellectual disability syndrome	ORPHA:485350
322	0.736	Intellectual developmental disorder with language impairment with or without autistic features	OMIM:613670
322	0.736	Tuberous sclerosis complex	ORPHA:805
322	0.736	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities	OMIM:619833
322	0.736	Tonne-Kalscheuer syndrome	OMIM:300978
322	0.736	Intellectual developmental disorder, autosomal dominant 29	OMIM:616078
322	0.736	Developmental and speech delay due to SOX5 deficiency	ORPHA:313892
322	0.736	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly	OMIM:620075
322	0.736	Tuberous sclerosis complex	ORPHA:805
322	0.736	Tuberous sclerosis complex	ORPHA:805
322	0.736	Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation	ORPHA:466950
322	0.736	Primrose syndrome	OMIM:259050
338	0.7351	DPAGT1-CDG	ORPHA:86309
339	0.7344	Intellectual developmental disorder, X-linked 98	OMIM:300912
340	0.7308	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	OMIM:615911
341	0.7302	Noonan syndrome 13	OMIM:619087
342	0.7297	ACTH-independent macronodular adrenal hyperplasia	OMIM:219080
342	0.7297	Pigmented nodular adrenocortical disease, primary, 2	OMIM:610475
342	0.7297	Pigmented nodular adrenocortical disease, primary, 1	OMIM:610489
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Narcolepsy type 1	ORPHA:2073
345	0.7286	Ataxia with isolated vitamin E deficiency	OMIM:277460
345	0.7286	Narcolepsy type 1	ORPHA:2073
354	0.7276	Senior-Boichis syndrome	ORPHA:84081
354	0.7276	Bilateral parasagittal parieto-occipital polymicrogyria	ORPHA:208441
354	0.7276	Senior-Boichis syndrome	ORPHA:84081
354	0.7276	Lujan-Fryns syndrome	OMIM:309520
358	0.7275	White-Sutton syndrome	ORPHA:468678
358	0.7275	Pettigrew syndrome	OMIM:304340
358	0.7275	Microcephaly 9, primary, autosomal recessive	OMIM:614852
358	0.7275	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	OMIM:620023
358	0.7275	Severe intellectual disability-progressive spastic diplegia syndrome	ORPHA:404473
358	0.7275	Intellectual developmental disorder, autosomal recessive 58	OMIM:617270
358	0.7275	Neurodevelopmental, jaw, eye, and digital syndrome	OMIM:618914
358	0.7275	Guanidinoacetate methyltransferase deficiency	ORPHA:382
358	0.7275	Intellectual developmental disorder, X-linked syndromic, Wu type	OMIM:300699
358	0.7275	Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome	ORPHA:544488
358	0.7275	Coffin-Siris syndrome 8	OMIM:618362
358	0.7275	Intellectual developmental disorder, autosomal dominant 44, with microcephaly	OMIM:617061
358	0.7275	Intellectual developmental disorder, X-linked syndromic, Nascimento type	OMIM:300860
371	0.7263	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	OMIM:617171
371	0.7263	Intellectual disability-epilepsy-extrapyramidal syndrome	ORPHA:468620
373	0.7256	Intellectual developmental disorder, autosomal dominant 39	OMIM:616521
373	0.7256	Neurodevelopmental disorder with spastic diplegia and visual defects	OMIM:615075
373	0.7256	X-linked intellectual disability due to GRIA3 mutations	ORPHA:364028
373	0.7256	Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome	ORPHA:476126
373	0.7256	Smith-Lemli-Opitz syndrome	OMIM:270400
373	0.7256	Gilles de la Tourette syndrome, susceptibility to	OMIM:137580
373	0.7256	Intellectual developmental disorder, autosomal recessive 38	OMIM:615516
373	0.7256	Joubert syndrome 1	OMIM:213300
373	0.7256	Congenital disorder of glycosylation, type IIa	OMIM:212066
373	0.7256	Microphthalmia, syndromic 1	OMIM:309800
373	0.7256	Tourette syndrome	OMIM:137580
373	0.7256	Joubert syndrome 20	OMIM:614970
373	0.7256	Hao-Fountain syndrome due to 16p13.2 microdeletion	ORPHA:500055
373	0.7256	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	OMIM:604317
387	0.7253	2q32q33 microdeletion syndrome	ORPHA:251019
387	0.7253	Witteveen-Kolk syndrome	OMIM:613406
389	0.724	Severe primary trimethylaminuria	ORPHA:468726
389	0.724	Mitochondrial complex III deficiency, nuclear type 2	OMIM:615157
391	0.7238	Neurodegeneration with brain iron accumulation 2B	OMIM:610217
391	0.7238	Metachromatic leukodystrophy	OMIM:250100
393	0.7227	Desanto-Shinawi syndrome	OMIM:616708
393	0.7227	Intellectual developmental disorder, X-linked 30	OMIM:300558
395	0.7208	Brain abnormalities, neurodegeneration, and dysosteosclerosis	OMIM:618476
396	0.7196	Atypical pantothenate kinase-associated neurodegeneration	ORPHA:216873
397	0.7189	Spinocerebellar ataxia 48	OMIM:618093
398	0.7152	Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	OMIM:610003
398	0.7152	Fatty acid hydroxylase-associated neurodegeneration	ORPHA:329308
398	0.7152	Classic galactosemia	ORPHA:79239
398	0.7152	Sandhoff disease, adult form	ORPHA:309169
398	0.7152	Epilepsy, progressive myoclonic, 12	OMIM:619191
403	0.7146	Glass syndrome	OMIM:612313
403	0.7146	Neurodevelopmental disorder with poor growth and behavioral abnormalities	OMIM:620242
403	0.7146	Lissencephaly 10	OMIM:618873
403	0.7146	Marbach-Schaaf neurodevelopmental syndrome	OMIM:619680
407	0.7139	Insomnia, fatal familial	OMIM:600072
407	0.7139	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	OMIM:605714
407	0.7139	Alzheimer disease 1, familial	OMIM:104300
407	0.7139	ABetaL34V amyloidosis	ORPHA:324703
407	0.7139	Cardiomyopathy, dilated, 1V	OMIM:613697
407	0.7139	Parkinson disease, susceptibility to	OMIM:168600
407	0.7139	Supranuclear palsy, progressive atypical	OMIM:260540
407	0.7139	Huntington disease	OMIM:143100
407	0.7139	Methylmalonic aciduria and homocystinuria, cblC type	OMIM:277400
407	0.7139	Alzheimer disease 2	OMIM:104310
407	0.7139	Dentatorubral-pallidoluysian atrophy	OMIM:125370
407	0.7139	Parkinson disease, susceptibility to	OMIM:168600
407	0.7139	Autosomal recessive spastic paraplegia type 78	ORPHA:513436
407	0.7139	Cerebellar ataxia	OMIM:604290
407	0.7139	Lewy body dementia, susceptibility to	OMIM:127750
407	0.7139	Parkinson disease, late-onset, susceptibility to	OMIM:168600
407	0.7139	Gaucher disease type 3	ORPHA:77261
407	0.7139	Parkinson disease 8	OMIM:607060
407	0.7139	Dementia, Lewy body	OMIM:127750
407	0.7139	Parkinson disease 4	OMIM:605543
407	0.7139	Parkinsonian-pyramidal syndrome	ORPHA:171695
407	0.7139	Parkinson disease, juvenile, type 2	OMIM:600116
407	0.7139	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
407	0.7139	Mitochondrial DNA depletion syndrome 4A (Alpers type)	OMIM:203700
407	0.7139	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
407	0.7139	Cerebrotendinous xanthomatosis	OMIM:213700
407	0.7139	Spinocerebellar ataxia type 12	ORPHA:98762
407	0.7139	Wolfram syndrome	ORPHA:3463
407	0.7139	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	OMIM:609286
407	0.7139	Progressive myoclonic epilepsy type 1	ORPHA:308
407	0.7139	Autosomal recessive spastic paraplegia type 46	ORPHA:320391
407	0.7139	HARP syndrome	OMIM:607236
407	0.7139	Kohlschutter-Tonz syndrome	OMIM:226750
407	0.7139	Dementia, familial Danish	OMIM:117300
407	0.7139	Leukoencephalopathy, progressive, with ovarian failure	OMIM:615889
407	0.7139	Parkinson disease, susceptibility to	OMIM:168600
407	0.7139	Amyotrophic lateral sclerosis 23	OMIM:617839
407	0.7139	Spinal muscular atrophy with progressive myoclonic epilepsy	OMIM:159950
407	0.7139	Wilson disease	OMIM:277900
407	0.7139	Spinocerebellar ataxia 10	OMIM:603516
407	0.7139	Amyotrophic lateral sclerosis, susceptibility to, 13	OMIM:183090
407	0.7139	Spinocerebellar ataxia type 2	ORPHA:98756
407	0.7139	Parkinson disease, late-onset, susceptibility to	OMIM:168600
407	0.7139	Spinocerebellar ataxia 2	OMIM:183090
407	0.7139	Machado-Joseph disease	OMIM:109150
407	0.7139	Hydrocephalus, normal pressure, 1	OMIM:236690
407	0.7139	Parkinson disease 22, autosomal dominant	OMIM:616710
407	0.7139	Wolfram syndrome	ORPHA:3463
407	0.7139	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	OMIM:618564
407	0.7139	Autosomal dominant spastic paraplegia type 73	ORPHA:444099
407	0.7139	Cerebral amyloid angiopathy	OMIM:105150
407	0.7139	Imerslund-Grasbeck syndrome 1	OMIM:261100
407	0.7139	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	OMIM:617070
407	0.7139	Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency	ORPHA:329314
407	0.7139	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant	OMIM:162350
407	0.7139	Autosomal dominant optic atrophy, classic form	ORPHA:98673
407	0.7139	Amyotrophic lateral sclerosis 19	OMIM:615515
407	0.7139	Xeroderma pigmentosum, type F/Cockayne syndrome	OMIM:278760
407	0.7139	Cockayne syndrome, type A	OMIM:216400
407	0.7139	Parkinsonian-pyramidal syndrome	ORPHA:171695
407	0.7139	Adult polyglucosan body disease	ORPHA:206583
407	0.7139	Glutaryl-CoA dehydrogenase deficiency	ORPHA:25
407	0.7139	Parkinson disease, age of onset, modifier	OMIM:168600
407	0.7139	Popliteal pterygium syndrome 1	OMIM:119500
407	0.7139	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
407	0.7139	Adult-onset autosomal dominant leukodystrophy	ORPHA:99027
407	0.7139	Chédiak-Higashi syndrome	ORPHA:167
407	0.7139	Amyotrophic lateral sclerosis 21	OMIM:606070
407	0.7139	Vocal cord and pharyngeal distal myopathy	ORPHA:600
407	0.7139	Spinocerebellar ataxia type 43	ORPHA:497764
407	0.7139	Charcot-Marie-Tooth disease, axonal, type 2T	OMIM:617017
407	0.7139	Alzheimer disease, susceptibility to	OMIM:104300
407	0.7139	Mitochondrial complex I deficiency, nuclear type 12	OMIM:301020
407	0.7139	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
407	0.7139	Niemann-Pick disease, type C1	OMIM:257220
407	0.7139	Niemann-pick disease, type C2	OMIM:607625
407	0.7139	Autosomal dominant optic atrophy, classic form	ORPHA:98673
407	0.7139	Basal ganglia calcification, idiopathic, 4	OMIM:615007
407	0.7139	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
407	0.7139	Cerebellar ataxia-hypogonadism syndrome	ORPHA:1173
407	0.7139	?Epilepsy, progressive myoclonic, 10	OMIM:616640
407	0.7139	Methylmalonic aciduria and homocystinuria, cblC type, digenic	OMIM:277400
407	0.7139	Progressive myoclonic epilepsy type 1	ORPHA:308
407	0.7139	Waisman syndrome	OMIM:311510
407	0.7139	Cerebellar ataxia and hypogonadotropic hypogonadism	OMIM:212840
407	0.7139	Cerebellar ataxia-hypogonadism syndrome	ORPHA:1173
407	0.7139	Spinocerebellar ataxia 49	OMIM:619806
407	0.7139	Progressive myoclonic epilepsy type 1	ORPHA:308
407	0.7139	Encephalopathy, familial, with neuroserpin inclusion bodies	OMIM:604218
407	0.7139	Dementia, Lewy body	OMIM:127750
407	0.7139	Amyotrophic lateral sclerosis 27, juvenile	OMIM:620285
407	0.7139	Epilepsy, familial adult myoclonic, 2	OMIM:607876
407	0.7139	Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to	OMIM:105500
407	0.7139	Primary dystonia, DYT4 type	ORPHA:98805
407	0.7139	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	OMIM:603041
407	0.7139	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
503	0.713	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type	OMIM:300534
503	0.713	Vulto-van Silfout-de Vries syndrome	OMIM:615828
503	0.713	Intellectual developmental disorder, X-linked syndromic, Cabezas type	OMIM:300354
503	0.713	Obesity, morbid, due to leptin receptor deficiency	OMIM:614963
503	0.713	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	ORPHA:457279
503	0.713	Velocardiofacial syndrome	OMIM:192430
509	0.7115	Spinocerebellar ataxia type 10	ORPHA:98761
509	0.7115	FRAXE intellectual disability	ORPHA:100973
509	0.7115	Intellectual developmental disorder, X-linked 109	OMIM:309548
509	0.7115	Kleefstra syndrome 1	OMIM:610253
509	0.7115	Mucopolysaccharidosis type IIID	OMIM:252940
509	0.7115	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development	OMIM:152950
509	0.7115	Developmental delay-facial dysmorphism syndrome due to MED13L deficiency	ORPHA:369891
509	0.7115	Intellectual developmental disorder with paroxysmal dyskinesia or seizures	OMIM:619150
517	0.7087	Raynaud-Claes syndrome	OMIM:300114
517	0.7087	Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion	ORPHA:284169
517	0.7087	ADNP syndrome	ORPHA:404448
517	0.7087	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	OMIM:620292
517	0.7087	Hyperprolinemia type 2	ORPHA:79101
517	0.7087	Sotos syndrome	ORPHA:821
517	0.7087	Intellectual developmental disorder, autosomal dominant 54	OMIM:617799
517	0.7087	Tatton-Brown-Rahman syndrome	ORPHA:404443
517	0.7087	Intellectual developmental disorder, X-linked 9	OMIM:309549
517	0.7087	Glycine encephalopathy1	OMIM:605899
517	0.7087	Intellectual developmental disorder, autosomal dominant 42	OMIM:616973
517	0.7087	Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum	OMIM:620250
517	0.7087	Intellectual developmental disorder, autosomal dominant 43	OMIM:616977
517	0.7087	Nizon-Isidor syndrome	OMIM:618872
517	0.7087	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	OMIM:618321
517	0.7087	Neurodevelopmental disorder with central and peripheral motor dysfunction	OMIM:618356
517	0.7087	Macrocephaly, acquired, with impaired intellectual development	OMIM:618286
517	0.7087	Macrocephaly-intellectual disability-left ventricular non compaction syndrome	ORPHA:466791
517	0.7087	Sotos syndrome	ORPHA:821
517	0.7087	Rauch-Steindl syndrome	OMIM:619695
517	0.7087	CK syndrome	OMIM:300831
517	0.7087	CK syndrome	ORPHA:251383
517	0.7087	Female restricted epilepsy with intellectual disability	ORPHA:101039
517	0.7087	Chung-Jansen syndrome	OMIM:617991
517	0.7087	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
517	0.7087	PYCR2-related microcephaly-progressive leukoencephalopathy	ORPHA:481152
517	0.7087	Neurodevelopmental disorder with speech impairment and dysmorphic facies	OMIM:619056
517	0.7087	Luscan-Lumish syndrome	OMIM:616831
517	0.7087	Sotos syndrome	ORPHA:821
517	0.7087	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
517	0.7087	Intellectual developmental disorder, X-linked 111	OMIM:301107
517	0.7087	Floating-Harbor syndrome	ORPHA:2044
517	0.7087	?Intellectual developmental disorder, X-linked 107	OMIM:301013
517	0.7087	Developmental delay with variable intellectual impairment and behavioral abnormalities	OMIM:618430
517	0.7087	Intellectual developmental disorder, autosomal dominant 49	OMIM:617752
517	0.7087	Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome	ORPHA:391307
517	0.7087	Parkinsonism-dystonia 3, childhood-onset	OMIM:619738
554	0.6976	AGel amyloidosis	ORPHA:85448
555	0.6959	Gaucher disease, perinatal lethal	OMIM:608013
556	0.6912	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	OMIM:614756
556	0.6912	Autism, susceptibility to, X-linked 4	OMIM:300830
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Epilepsy, idiopathic generalized, susceptibility to, 15	OMIM:618357
556	0.6912	Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders	OMIM:300491
556	0.6912	X-linked epilepsy-learning disabilities-behavior disorders syndrome	ORPHA:85294
556	0.6912	Phelan-McDermid syndrome	OMIM:606232
556	0.6912	KDM5C-related syndromic X-linked intellectual disability	ORPHA:85279
556	0.6912	Wiedemann-Steiner syndrome	OMIM:605130
556	0.6912	Developmental and epileptic encephalopathy 33	OMIM:616409
556	0.6912	Usmani-Riazuddin syndrome, autosomal recessive	OMIM:619548
556	0.6912	Congenital disorder of glycosylation, type Ij	OMIM:608093
556	0.6912	?Polymicrogyria, bilateral temporooccipital	OMIM:612691
556	0.6912	X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome	ORPHA:85329
556	0.6912	Fried syndrome	ORPHA:85335
556	0.6912	Cerebral creatine deficiency syndrome 2	OMIM:612736
556	0.6912	Bachmann-Bupp syndrome	OMIM:619075
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	OMIM:618825
556	0.6912	X-linked intellectual disability, Nascimento type	ORPHA:163956
556	0.6912	MORM syndrome	ORPHA:75858
556	0.6912	Hao-Fountain syndrome	OMIM:616863
556	0.6912	Wilson disease	ORPHA:905
556	0.6912	X-linked intellectual disability, Cabezas type	ORPHA:85293
556	0.6912	Intellectual developmental disorder, X-linked syndromic 34	OMIM:300967
556	0.6912	Sotos syndrome	OMIM:117550
556	0.6912	Developmental and epileptic encephalopathy 9	OMIM:300088
556	0.6912	Floating-Harbor syndrome	OMIM:136140
556	0.6912	Intellectual developmental disorder, autosomal recessive 39	OMIM:615541
556	0.6912	WARS2-related combined oxidative phosphorylation defect	ORPHA:572798
556	0.6912	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	OMIM:617710
556	0.6912	Intellectual developmental disorder with poor growth and with or without seizures or ataxia	OMIM:618808
556	0.6912	Intellectual disability-strabismus syndrome	ORPHA:363528
556	0.6912	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	OMIM:615286
556	0.6912	Lessel-Kreienkamp syndrome	OMIM:619149
556	0.6912	ANK3-related intellectual disability-sleep disturbance syndrome	ORPHA:356996
556	0.6912	Intellectual developmental disorder, autosomal recessive 37	OMIM:615493
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome 1	OMIM:135900
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Developmental delay, language impairment, and ocular abnormalities	OMIM:620141
556	0.6912	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	ORPHA:369939
556	0.6912	Shukla-Vernon syndrome	OMIM:301029
556	0.6912	Cerebellofaciodental syndrome	OMIM:616202
556	0.6912	Intellectual developmental disorder, autosomal recessive 66	OMIM:618221
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	Joubert syndrome 5	OMIM:610188
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	X-linked intellectual disability-hypotonia-movement disorder syndrome	ORPHA:457260
556	0.6912	Intellectual developmental disorder, X-linked syndromic, Snijders Blok type	OMIM:300958
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Ritscher-Schinzel syndrome 4	OMIM:619435
556	0.6912	Neurodevelopmental disorder with microcephaly and structural brain anomalies	OMIM:618492
556	0.6912	MEND syndrome	ORPHA:401973
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	MEHMO syndrome	OMIM:300148
556	0.6912	Spastic paraplegia 64, autosomal recessive	OMIM:615683
556	0.6912	Autosomal recessive spastic paraplegia type 64	ORPHA:401810
556	0.6912	Intellectual developmental disorder with short stature, facial anomalies, and speech defects	OMIM:606220
556	0.6912	Intellectual developmental disorder, X-linked 104	OMIM:300983
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	?Abnormal hair, joint laxity, and developmental delay	OMIM:261990
556	0.6912	Intellectual developmental disorder, autosomal recessive 59	OMIM:617323
556	0.6912	Intellectual developmental disorder with short stature and behavioral abnormalities	OMIM:618687
556	0.6912	Intellectual developmental disorder, X-linked 1	OMIM:309530
556	0.6912	Developmental delay with variable intellectual disability and dysmorphic facies	OMIM:620098
556	0.6912	Juvenile myoclonic epilepsy	ORPHA:307
556	0.6912	Epilepsy nocturnal frontal lobe, 5	OMIM:615005
556	0.6912	Diets-Jongmans syndrome	OMIM:618846
556	0.6912	Intellectual developmental disorder, autosomal dominant 65	OMIM:619320
556	0.6912	Intellectual developmental disorder, autosomal recessive 65	OMIM:618109
556	0.6912	Intellectual developmental disorder, autosomal dominant 51	OMIM:617788
556	0.6912	Microcephaly 4, primary, autosomal recessive	OMIM:604321
556	0.6912	Intellectual developmental disorder, autosomal recessive 64	OMIM:618103
556	0.6912	Intellectual developmental disorder, autosomal recessive 27	OMIM:614340
556	0.6912	?Intellectual developmental disorder, autosomal recessive 52	OMIM:616887
556	0.6912	Cerebellar, ocular, craniofacial, and genital syndrome	OMIM:618479
556	0.6912	Rafiq syndrome	OMIM:614202
556	0.6912	Mannosidosis, beta	OMIM:248510
556	0.6912	Basel-Vanagaite-Smirin-Yosef syndrome	ORPHA:464738
556	0.6912	Intellectual developmental disorder, autosomal recessive 72	OMIM:618665
556	0.6912	N-acetylglutamate synthase deficiency	OMIM:237310
556	0.6912	Neurodevelopmental disorder with or without early-onset generalized epilepsy	OMIM:619157
556	0.6912	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	OMIM:301039
556	0.6912	Lowe syndrome	OMIM:309000
556	0.6912	Schuurs-Hoeijmakers syndrome	OMIM:615009
556	0.6912	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities	OMIM:620191
556	0.6912	Glycosylphosphatidylinositol biosynthesis defect 17	OMIM:618010
556	0.6912	Hyperphosphatasia with impaired intellectual development syndrome 6	OMIM:616809
556	0.6912	Hyperprolinemia, type I	OMIM:239500
556	0.6912	?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language	OMIM:620038
556	0.6912	Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome	ORPHA:488627
556	0.6912	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	OMIM:618342
556	0.6912	Jawad syndrome	OMIM:251255
556	0.6912	Intellectual developmental disorder, autosomal recessive 61	OMIM:617773
556	0.6912	Neurodevelopmental disorder with microcephaly, ataxia, and seizures	OMIM:617709
556	0.6912	Microcephaly 14, primary, autosomal recessive	OMIM:616402
556	0.6912	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	OMIM:619121
556	0.6912	Brown-Vialetto-Van Laere syndrome 2	OMIM:614707
556	0.6912	Cerebral creatine deficiency syndrome 1	OMIM:300352
556	0.6912	Nicolaides-Baraitser syndrome	OMIM:601358
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Coffin-Siris syndrome	ORPHA:1465
556	0.6912	Radio-Tartaglia syndrome	OMIM:619312
556	0.6912	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	OMIM:612716
556	0.6912	Congenital disorder of glycosylation, type Iw, autosomal dominant	OMIM:619714
556	0.6912	Fatal infantile lactic acidosis with methylmalonic aciduria	ORPHA:17
556	0.6912	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	OMIM:301066
556	0.6912	3-methylglutaconic aciduria type 9	ORPHA:505216
556	0.6912	3-methylglutaconic aciduria, type IX	OMIM:617698
556	0.6912	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities	OMIM:619470
556	0.6912	Neurodevelopmental disorder with microcephaly, short stature, and speech delay	OMIM:620027
556	0.6912	Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism	OMIM:619244
556	0.6912	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities	OMIM:620270
556	0.6912	Neurodevelopmental disorder with hypotonia and gross motor and speech delay	OMIM:619639
556	0.6912	Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder	ORPHA:500180
556	0.6912	Mitochondrial complex III deficiency, nuclear type 7	OMIM:615824
556	0.6912	?Urocanase deficiency	OMIM:276880
556	0.6912	Intellectual developmental disorder, X-linked 99	OMIM:300919
556	0.6912	Dystonia 30	OMIM:619291
556	0.6912	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies	OMIM:618659
556	0.6912	Intellectual developmental disorder, autosomal dominant 30	OMIM:616083
684	0.6903	Ceroid lipofuscinosis, neuronal, 1	OMIM:256730
684	0.6903	Spinocerebellar ataxia with epilepsy	ORPHA:254881
684	0.6903	Kosaki overgrowth syndrome	OMIM:616592
684	0.6903	Hyperphenylalaninemia, BH4-deficient, B	OMIM:233910
684	0.6903	Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency	ORPHA:88639
684	0.6903	Mitochondrial complex I deficiency, nuclear type 33	OMIM:618253
684	0.6903	Hyperphenylalaninemia, BH4-deficient, A	OMIM:261640
684	0.6903	Hyperphenylalaninemia, BH4-deficient, C	OMIM:261630
684	0.6903	Hypermanganesemia with dystonia 2	OMIM:617013
693	0.6836	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
693	0.6836	Adult-onset dystonia-parkinsonism	ORPHA:199351
693	0.6836	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	OMIM:619141
693	0.6836	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
693	0.6836	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
693	0.6836	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	OMIM:615422
693	0.6836	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	OMIM:616208
693	0.6836	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	OMIM:300857
701	0.6745	CHIME syndrome	OMIM:280000
702	0.6677	Classic progressive supranuclear palsy syndrome	ORPHA:240071
702	0.6677	Megalencephalic leukoencephalopathy with subcortical cysts 2A	OMIM:613925
702	0.6677	Deafness, congenital, and adult-onset progressive leukoencephalopathy	OMIM:619196
702	0.6677	Metachromatic leukodystrophy due to SAP-b deficiency	OMIM:249900
706	0.6589	Prader-Willi syndrome due to translocation	ORPHA:177907
707	0.6537	Hereditary sensory and autonomic neuropathy type 4	ORPHA:642
708	0.6484	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
708	0.6484	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
708	0.6484	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
708	0.6484	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
712	0.647	Norrie disease	ORPHA:649
713	0.6455	Dihydropyrimidine dehydrogenase deficiency	ORPHA:1675
714	0.6433	Developmental delay with or without intellectual impairment or behavioral abnormalities	OMIM:619575
715	0.6406	Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome	ORPHA:363686
716	0.6375	Hypotonia-speech impairment-severe cognitive delay syndrome	ORPHA:371364
716	0.6375	Pontocerebellar hypoplasia, type 11	OMIM:617695
716	0.6375	Hypotonia-speech impairment-severe cognitive delay syndrome	ORPHA:371364
719	0.6354	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome	ORPHA:522077
720	0.6343	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	OMIM:614254
720	0.6343	Developmental and epileptic encephalopathy 104	OMIM:619970
720	0.6343	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	OMIM:618339
723	0.6329	2q23.1 microdeletion syndrome	ORPHA:228402
723	0.6329	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	OMIM:618718
725	0.6315	Fragile X syndrome	ORPHA:908
725	0.6315	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	OMIM:618929
725	0.6315	Smith-Magenis syndrome	ORPHA:819
725	0.6315	Smith-Magenis syndrome	ORPHA:819
725	0.6315	Oculocerebrorenal syndrome of Lowe	ORPHA:534
725	0.6315	Neurodevelopmental disorder with hypotonia and brain abnormalities	OMIM:619512
725	0.6315	Smith-Magenis syndrome	ORPHA:819
725	0.6315	Macrocephaly-developmental delay syndrome	ORPHA:397612
725	0.6315	Intellectual developmental disorder, autosomal recessive 41	OMIM:615637
725	0.6315	Smith-Magenis syndrome	ORPHA:819
725	0.6315	Neurodevelopmental disorder with dystonia and seizures	OMIM:619922
736	0.6303	Smith-Magenis syndrome	OMIM:182290
737	0.628	Spastic paraplegia 11, autosomal recessive	OMIM:604360
737	0.628	Ceroid lipofuscinosis, neuronal, 11	OMIM:614706
737	0.628	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	OMIM:617145
737	0.628	Sneddon syndrome	OMIM:182410
737	0.628	Spinocerebellar ataxia type 17	ORPHA:98759
737	0.628	Mitochondrial membrane protein-associated neurodegeneration	ORPHA:289560
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Dravet syndrome	OMIM:607208
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Parkinson disease 20, early-onset	OMIM:615530
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Alternating hemiplegia of childhood 2	OMIM:614820
737	0.628	Striatal degeneration, autosomal dominant	OMIM:616922
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8	OMIM:617900
737	0.628	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
737	0.628	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Mohr-Tranebjaerg syndrome	OMIM:304700
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Ataxia with vitamin E deficiency	ORPHA:96
737	0.628	Autosomal recessive spastic paraplegia type 35	ORPHA:171629
737	0.628	Spastic paraplegia 35, autosomal recessive	OMIM:612319
737	0.628	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	ORPHA:2590
737	0.628	Mitochondrial DNA depletion syndrome 20 (MNGIE type)	OMIM:619780
737	0.628	Early-onset Lafora body disease	ORPHA:324290
737	0.628	Epilepsy, progressive myoclonic 4, with or without renal failure	OMIM:254900
737	0.628	Neurodegeneration, childhood-onset, with brain atrophy	OMIM:617672
737	0.628	Immunodeficiency 83, susceptibility to viral infections	OMIM:613002
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Benign familial neonatal-infantile seizures	ORPHA:140927
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Saccharopinuria	ORPHA:3124
737	0.628	Developmental malformations-deafness-dystonia syndrome	ORPHA:79107
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Sengers syndrome	OMIM:212350
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Spastic paraplegia 48, autosomal recessive	OMIM:613647
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Spinocerebellar ataxia 7	OMIM:164500
737	0.628	Spinocerebellar ataxia type 7	ORPHA:94147
737	0.628	Encephalopathy, progressive, with or without lipodystrophy	OMIM:615924
737	0.628	Combined oxidative phosphorylation deficiency 27	OMIM:616672
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Neurodegeneration with brain iron accumulation 6	OMIM:615643
737	0.628	Mitochondrial complex IV deficiency, nuclear type 7	OMIM:619051
737	0.628	Cerebroretinal microangiopathy with calcifications and cysts	OMIM:612199
737	0.628	Ceroid lipofuscinosis, neuronal, 10	OMIM:610127
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	ORPHA:137898
737	0.628	Woodhouse-Sakati syndrome	ORPHA:3464
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Xeroderma pigmentosum, group D	OMIM:278730
737	0.628	?De Sanctis-Cacchione syndrome	OMIM:278800
737	0.628	?De Sanctis-Cacchione syndrome	OMIM:278800
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Fucosidosis	OMIM:230000
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Mucopolysaccharidosis type 2, severe form	ORPHA:217085
737	0.628	Mucopolysaccharidosis type 2, attenuated form	ORPHA:217093
737	0.628	Basal ganglia calcification, idiopathic, 8, autosomal recessive	OMIM:618824
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Epilepsy, progressive myoclonic 7	OMIM:616187
737	0.628	Spastic ataxia 2, autosomal recessive	OMIM:611302
737	0.628	Charcot-Marie-Tooth disease, axonal, type 2A2A	OMIM:609260
737	0.628	Ceroid lipofuscinosis, neuronal, 7	OMIM:610951
737	0.628	Homocystinuria due to methylene tetrahydrofolate reductase deficiency	ORPHA:395
737	0.628	Nijmegen breakage syndrome	ORPHA:647
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Neurocutaneous melanosis, somatic	OMIM:249400
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Leukodystrophy, hypomyelinating, 21	OMIM:619310
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Benign familial neonatal-infantile seizures	ORPHA:140927
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	RENI syndrome	OMIM:617575
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	OMIM:618868
737	0.628	Niemann-Pick disease, type B	OMIM:607616
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Spastic paraplegia 80, autosomal dominant	OMIM:618418
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
737	0.628	Xeroderma pigmentosum, group A	OMIM:278700
737	0.628	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
845	0.6228	Intellectual developmental disorder, X-linked syndromic, Billuart type	OMIM:300486
845	0.6228	Insensitivity to pain, congenital, with anhidrosis	OMIM:256800
847	0.6213	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3	OMIM:619950
848	0.6185	Obsessive-compulsive disorder	OMIM:164230
848	0.6185	Obsessive-compulsive disorder, susceptibility to	OMIM:164230
848	0.6185	Alazami syndrome	ORPHA:319671
848	0.6185	Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome	ORPHA:447997
848	0.6185	X-linked intellectual disability-short stature-overweight syndrome	ORPHA:457240
848	0.6185	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	OMIM:213980
854	0.6083	Alpha-thalassemia-X-linked intellectual disability syndrome	ORPHA:847
854	0.6083	?Intellectual developmental disorder, autosomal recessive 76	OMIM:619931
854	0.6083	Developmental and epileptic encephalopathy 31A, autosomal dominant	OMIM:616346
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Pitt-Hopkins syndrome	OMIM:610954
854	0.6083	Smith-Lemli-Opitz syndrome	ORPHA:818
854	0.6083	Microphthalmia, Lenz type	ORPHA:568
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	OMIM:617820
854	0.6083	Kleefstra syndrome due to a point mutation	ORPHA:261652
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	?Charcot-Marie-Tooth disease, recessive intermediate, B	OMIM:613641
854	0.6083	Developmental and epileptic encephalopathy 59	OMIM:617904
854	0.6083	Keratoderma hereditarium mutilans	ORPHA:494
854	0.6083	Neurodevelopmental disorder with absent language and variable seizures	OMIM:618707
854	0.6083	Neurodevelopmental disorder with language impairment and behavioral abnormalities	OMIM:618917
854	0.6083	Baker-Gordon syndrome	OMIM:618218
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Neurodevelopmental disorder with involuntary movements	OMIM:617493
854	0.6083	Lesch-Nyhan syndrome	OMIM:300322
854	0.6083	Harlequin ichthyosis	ORPHA:457
854	0.6083	Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome	ORPHA:457351
854	0.6083	Bainbridge-Ropers syndrome	OMIM:615485
854	0.6083	Dias-Logan syndrome	OMIM:617101
854	0.6083	Microphthalmia, Lenz type	ORPHA:568
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Intellectual developmental disorder, autosomal recessive 2	OMIM:607417
854	0.6083	Cerebrofacioarticular syndrome	ORPHA:314679
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Cerebrofacioarticular syndrome	ORPHA:314679
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Neurodevelopmental disorder with hypotonia, seizures, and absent language	OMIM:617268
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Cortical dysplasia, complex, with other brain malformations 2	OMIM:615282
854	0.6083	Kleefstra syndrome due to a point mutation	ORPHA:261652
854	0.6083	Kleefstra syndrome 2	OMIM:617768
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Cornelia de Lange syndrome 1	OMIM:122470
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Houge-Janssens syndrome 3	OMIM:618354
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Brunet-Wagner neurodevelopmental syndrome	OMIM:619690
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	RERE-related neurodevelopmental syndrome	ORPHA:494344
854	0.6083	Developmental and epileptic encephalopathy 64	OMIM:618004
854	0.6083	X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome	ORPHA:435938
854	0.6083	Coffin-Lowry syndrome	ORPHA:192
854	0.6083	Microcephalic cortical malformations-short stature due to RTTN deficiency	ORPHA:468631
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	Nabais Sa-de Vries syndrome, type 1	OMIM:618828
854	0.6083	Short stature, developmental delay, and congenital heart defects	OMIM:617044
854	0.6083	Transketolase deficiency	ORPHA:488618
854	0.6083	Early infantile epileptic encephalopathy	ORPHA:1934
854	0.6083	1p36 deletion syndrome	ORPHA:1606
854	0.6083	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	OMIM:618760
854	0.6083	Intellectual developmental disorder, autosomal recessive 43	OMIM:615817
926	0.6012	Gaucher disease, type II	OMIM:230900
926	0.6012	Developmental and epileptic encephalopathy 53	OMIM:617389
926	0.6012	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	OMIM:612075
926	0.6012	Ceroid lipofuscinosis, neuronal, 5	OMIM:256731
926	0.6012	Ceroid lipofuscinosis, neuronal, 6A	OMIM:601780
926	0.6012	Rett syndrome, atypical	OMIM:312750
926	0.6012	Cockayne syndrome type 3	ORPHA:90324
926	0.6012	Leukodystrophy, adult-onset, autosomal dominant	OMIM:169500
926	0.6012	Benign familial infantile epilepsy	ORPHA:306
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	Benign familial infantile epilepsy	ORPHA:306
926	0.6012	Krabbe disease, atypical	OMIM:611722
926	0.6012	Mucopolysaccharidosis Ih	OMIM:607014
926	0.6012	Benign familial infantile epilepsy	ORPHA:306
926	0.6012	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
926	0.6012	Cockayne syndrome type 3	ORPHA:90324
926	0.6012	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
926	0.6012	Cockayne syndrome type 3	ORPHA:90324
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	Benign familial infantile epilepsy	ORPHA:306
926	0.6012	Benign familial infantile epilepsy	ORPHA:306
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	Schizophrenia	OMIM:181500
926	0.6012	Schizophrenia	OMIM:181500
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	COG2-CDG	ORPHA:435934
926	0.6012	Cystinosis, nephropathic	OMIM:219800
926	0.6012	Mitochondrial complex III deficiency, nuclear type 6	OMIM:615453
926	0.6012	Schizophrenia	OMIM:181500
926	0.6012	Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure	OMIM:620315
926	0.6012	Krabbe disease	OMIM:245200
926	0.6012	Galactokinase deficiency	ORPHA:79237
926	0.6012	Mucopolysaccharidosis type IIIC (Sanfilippo C)	OMIM:252930
926	0.6012	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	ORPHA:70472
926	0.6012	Mucolipidosis IV	OMIM:252650
926	0.6012	Combined oxidative phosphorylation deficiency 37	OMIM:618329
926	0.6012	Combined oxidative phosphorylation deficiency 15	OMIM:614947
926	0.6012	Spinocerebellar ataxia type 4	ORPHA:98765
926	0.6012	Griscelli syndrome, type 2	OMIM:607624
926	0.6012	ANE syndrome	ORPHA:157954
926	0.6012	?Alopecia, neurologic defects, and endocrinopathy syndrome	OMIM:612079
926	0.6012	Schizophrenia, susceptibility to	OMIM:181500
926	0.6012	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	OMIM:618384
926	0.6012	Mitochondrial complex I deficiency, nuclear type 31	OMIM:618251
926	0.6012	Revesz syndrome	OMIM:268130
926	0.6012	Mitochondrial DNA depletion syndrome, myopathic form	ORPHA:254875
973	0.5943	Fragile X syndrome	OMIM:300624
973	0.5943	Aicardi-Goutieres syndrome 1, dominant and recessive	OMIM:225750
973	0.5943	Monosomy 22q13.3	ORPHA:48652
973	0.5943	Rubinstein-Taybi syndrome 1	OMIM:180849
973	0.5943	?Trichotillomania	OMIM:613229
973	0.5943	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	OMIM:614388
973	0.5943	X-linked creatine transporter deficiency	ORPHA:52503
973	0.5943	?N-acetylaspartate deficiency	OMIM:614063
973	0.5943	Microhydranencephaly	OMIM:605013
973	0.5943	Schaaf-Yang syndrome	OMIM:615547
973	0.5943	MAGEL2-related Prader-Willi-like syndrome	ORPHA:398069
973	0.5943	Hypoxanthine guanine phosphoribosyltransferase partial deficiency	ORPHA:79233
973	0.5943	CHARGE syndrome	OMIM:214800
973	0.5943	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	OMIM:618922
973	0.5943	Hypomagnesemia, seizures, and impaired intellectual development 2	OMIM:618314
973	0.5943	Developmental and epileptic encephalopathy 36	OMIM:300884
973	0.5943	Spinocerebellar ataxia, autosomal recessive 31	OMIM:619422
973	0.5943	Temtamy syndrome	OMIM:218340
973	0.5943	Intellectual developmental disorder, autosomal dominant 59	OMIM:618522
973	0.5943	Intellectual developmental disorder, autosomal recessive 77	OMIM:619988
973	0.5943	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	OMIM:619005
973	0.5943	DEEAH syndrome	OMIM:619004
973	0.5943	Alzahrani-Kuwahara syndrome	OMIM:619268
996	0.5777	Sandhoff disease, infantile, juvenile, and adult forms	OMIM:268800
996	0.5777	Severe neurodegenerative syndrome with lipodystrophy	ORPHA:363400
996	0.5777	GM1-gangliosidosis, type II	OMIM:230600
996	0.5777	Autosomal recessive cerebelloparenchymal disorder type 3	ORPHA:1170
996	0.5777	Multiple sulfatase deficiency	ORPHA:585
996	0.5777	Multiple sulfatase deficiency	OMIM:272200
1002	0.5648	Helsmoortel-van der Aa syndrome	OMIM:615873
1003	0.5634	Porphyria due to ALA dehydratase deficiency	ORPHA:100924
1004	0.5575	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly	OMIM:618569
1004	0.5575	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities	OMIM:619103
1004	0.5575	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome	OMIM:619356
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Hyperammonemia due to N-acetylglutamate synthase deficiency	ORPHA:927
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1007	0.5567	Amyotrophic lateral sclerosis	ORPHA:803
1045	0.5555	Autosomal recessive spastic paraplegia type 20	ORPHA:101000
1046	0.548	Atypical Rett syndrome	ORPHA:3095
1046	0.548	Atypical Rett syndrome	ORPHA:3095
1046	0.548	Atypical Rett syndrome	ORPHA:3095
1046	0.548	Atypical Rett syndrome	ORPHA:3095
1046	0.548	Atypical Rett syndrome	ORPHA:3095
1051	0.5478	Intellectual developmental disorder, autosomal dominant 7	OMIM:614104
1051	0.5478	Christianson syndrome	ORPHA:85278
1053	0.5469	Lissencephaly type 1 due to doublecortin gene mutation	ORPHA:2148
1054	0.5464	Angelman syndrome	OMIM:105830
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
1055	0.545	Koolen-De Vries syndrome	OMIM:610443
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Kleefstra syndrome due to 9q34 microdeletion	ORPHA:96147
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Alobar holoprosencephaly	ORPHA:93925
1063	0.5445	Lobar holoprosencephaly	ORPHA:93924
1063	0.5445	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
1063	0.5445	Semilobar holoprosencephaly	ORPHA:220386
1130	0.5368	Pituitary adenoma 4, ACTH-secreting, somatic	OMIM:219090
1131	0.5365	Dystonia-11, myoclonic	OMIM:159900
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1132	0.5354	Adrenocortical carcinoma	ORPHA:1501
1138	0.534	Rolandic epilepsy	ORPHA:1945
1138	0.534	Dystonia-12	OMIM:128235
1138	0.534	Rapid-onset dystonia-parkinsonism	ORPHA:71517
1138	0.534	Rolandic epilepsy	ORPHA:1945
1138	0.534	Aromatic L-amino acid decarboxylase deficiency	OMIM:608643
1138	0.534	Hartnup disease	ORPHA:2116
1138	0.534	Autosomal dominant hypocalcemia	ORPHA:428
1138	0.534	Hartnup disease	ORPHA:2116
1138	0.534	Autosomal dominant hypocalcemia	ORPHA:428
1138	0.534	Tenorio syndrome	OMIM:616260
1138	0.534	Acrodermatitis enteropathica	OMIM:201100
1138	0.534	Rolandic epilepsy	ORPHA:1945
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1150	0.5281	Myoclonic-astatic epilepsy	ORPHA:1942
1157	0.5268	Leber congenital amaurosis 8	OMIM:613835
1157	0.5268	Leber congenital amaurosis 1	OMIM:204000
1157	0.5268	Leber congenital amaurosis 9	OMIM:608553
1157	0.5268	Leber congenital amaurosis 2	OMIM:204100
1157	0.5268	Leber congenital amaurosis 15	OMIM:613843
1162	0.5265	Beta-ketothiolase deficiency	ORPHA:134
1163	0.5237	Atypical teratoid rhabdoid tumor	ORPHA:99966
1163	0.5237	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	OMIM:141500
1163	0.5237	GM2 gangliosidosis, AB variant	ORPHA:309246
1163	0.5237	17q21.31 microdeletion syndrome	ORPHA:363958
1163	0.5237	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	OMIM:619651
1163	0.5237	Insulin-like growth factor I, resistance to	OMIM:270450
1169	0.5153	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	OMIM:617865
1169	0.5153	SATB2-associated syndrome due to a pathogenic variant	ORPHA:576283
1169	0.5153	Intellectual developmental disorder, X-linked syndromic, Christianson type	OMIM:300243
1169	0.5153	Bohring-Opitz syndrome	ORPHA:97297
1169	0.5153	Cornelia de Lange syndrome 5	OMIM:300882
1169	0.5153	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	OMIM:617807
1169	0.5153	Suleiman-El-Hattab syndrome	OMIM:618950
1169	0.5153	Skraban-Deardorff syndrome	OMIM:617616
1169	0.5153	Mowat-Wilson syndrome	OMIM:235730
1169	0.5153	Mowat-Wilson syndrome due to a ZEB2 point mutation	ORPHA:261552
1169	0.5153	Mowat-Wilson syndrome due to monosomy 2q22	ORPHA:261537
1180	0.514	Myoclonus-dystonia syndrome	ORPHA:36899
1180	0.514	Myoclonus-dystonia syndrome	ORPHA:36899
1180	0.514	Myoclonus-dystonia syndrome	ORPHA:36899
1180	0.514	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	OMIM:619725
1180	0.514	Myoclonus-dystonia syndrome	ORPHA:36899
1180	0.514	Teebi hypertelorism syndrome 1	OMIM:145420
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1186	0.5084	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
1202	0.505	Pseudohypoparathyroidism type 1A	ORPHA:79443
1202	0.505	Pseudohypoparathyroidism type 1B	ORPHA:94089
1202	0.505	Pseudohypoparathyroidism type 1C	ORPHA:79444
1202	0.505	Schwartz-Jampel syndrome	ORPHA:800
1202	0.505	Pseudohypoparathyroidism type 1B	ORPHA:94089
1202	0.505	Intellectual developmental disorder, autosomal dominant 52	OMIM:617796
1208	0.5035	Multiple sclerosis, susceptibility to, 1	OMIM:126200
1208	0.5035	Progressive external ophthalmoplegia, autosomal recessive 1	OMIM:258450
1208	0.5035	Spastic paraplegia 15, autosomal recessive	OMIM:270700
1208	0.5035	Intellectual developmental disorder, X-linked syndromic 13	OMIM:300055
1208	0.5035	Multiple sclerosis, susceptibility to, 1	OMIM:126200
1208	0.5035	Obesity due to leptin receptor gene deficiency	ORPHA:179494
1208	0.5035	Blepharophimosis-impaired intellectual development syndrome	OMIM:619293
1208	0.5035	Troyer syndrome	OMIM:275900
1208	0.5035	Dysautonomia, familial	OMIM:223900
1208	0.5035	Intellectual developmental disorder, autosomal recessive 54	OMIM:617028
1208	0.5035	Hartnup disorder	OMIM:234500
1208	0.5035	Acrodermatitis enteropathica	ORPHA:37
1208	0.5035	Spastic paraplegia 26, autosomal recessive	OMIM:609195
1208	0.5035	Sarcosinemia	ORPHA:3129
1208	0.5035	Wilson-Turner syndrome	ORPHA:3459
1208	0.5035	Cushing syndrome, ACTH-independent adrenal, somatic	OMIM:615830
1208	0.5035	?Microcephaly 29, primary, autosomal recessive	OMIM:620047
1208	0.5035	Neurodevelopmental disorder with hypotonia and dysmorphic facies	OMIM:619503
1208	0.5035	Mitochondrial complex III deficiency, nuclear type 1	OMIM:124000
1208	0.5035	?Spastic ataxia 4, autosomal recessive	OMIM:613672
1208	0.5035	Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome	ORPHA:254343
1208	0.5035	Bartter syndrome type 4	ORPHA:89938
1208	0.5035	Bartter syndrome type 4	ORPHA:89938
1208	0.5035	Bartter syndrome type 4	ORPHA:89938
1208	0.5035	Wilson-Turner syndrome	OMIM:309585
1208	0.5035	Wilson-Turner syndrome	ORPHA:3459
1208	0.5035	Neurodevelopmental disorder with or without variable brain abnormalities	OMIM:618443
1208	0.5035	Multiple sclerosis, disease progression, modifier of	OMIM:126200
1208	0.5035	Phosphoglycerate kinase 1 deficiency	OMIM:300653
1208	0.5035	8q24.3 microdeletion syndrome	ORPHA:508488
1208	0.5035	RIDDLE syndrome	ORPHA:420741
1208	0.5035	Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation	ORPHA:300570
1240	0.4924	Lopes-Maciel-Rodan syndrome	OMIM:617435
1240	0.4924	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	OMIM:615688
1240	0.4924	Rett syndrome	ORPHA:778
1240	0.4924	MEHMO syndrome	ORPHA:85282
1240	0.4924	6-pyruvoyl-tetrahydropterin synthase deficiency	ORPHA:13
1240	0.4924	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	ORPHA:276580
1240	0.4924	Neurodevelopmental disorder with poor language and loss of hand skills	OMIM:617903
1240	0.4924	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1240	0.4924	GAND syndrome	OMIM:615074
1240	0.4924	Developmental and epileptic encephalopathy 47	OMIM:617166
1240	0.4924	CDKL5-deficiency disorder	ORPHA:505652
1240	0.4924	den Hoed-de Boer-Voisin syndrome	OMIM:619229
1240	0.4924	3-hydroxy-3-methylglutaric aciduria	ORPHA:20
1240	0.4924	HMG-CoA lyase deficiency	OMIM:246450
1240	0.4924	Alexander disease	OMIM:203450
1240	0.4924	Alopecia-intellectual disability syndrome 4	OMIM:618840
1240	0.4924	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	OMIM:615802
1240	0.4924	Sulfite oxidase deficiency	OMIM:272300
1240	0.4924	Autosomal dominant hyperinsulinism due to SUR1 deficiency	ORPHA:276575
1240	0.4924	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1240	0.4924	Mitochondrial complex IV deficiency, nuclear type 3	OMIM:619046
1240	0.4924	Familial gestational hyperthyroidism	ORPHA:99819
1240	0.4924	Familial hyperthyroidism due to mutations in TSH receptor	ORPHA:424
1240	0.4924	Combined oxidative phosphorylation deficiency 3	OMIM:610505
1240	0.4924	Developmental and epileptic encephalopathy 95	OMIM:618143
1240	0.4924	Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities	OMIM:618859
1240	0.4924	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	OMIM:618056
1240	0.4924	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	OMIM:613870
1240	0.4924	Neurodevelopmental disorder with seizures and gingival overgrowth	OMIM:619323
1269	0.4821	Intellectual disability-hypotonic facies syndrome, X-linked	OMIM:309580
1269	0.4821	Adult-onset cervical dystonia, DYT23 type	ORPHA:420492
1269	0.4821	HSD10 disease, infantile type	ORPHA:391428
1269	0.4821	You-Hoover-Fong syndrome	OMIM:616954
1269	0.4821	Pallister-Hall syndrome	ORPHA:672
1269	0.4821	Galloway-Mowat syndrome 6	OMIM:618347
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Glucocorticoid resistance	OMIM:615962
1275	0.4723	Porphyria, acute intermittent, nonerythroid variant	OMIM:176000
1275	0.4723	Celiac disease, susceptibility to	OMIM:212750
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Congenital tufting enteropathy	ORPHA:92050
1275	0.4723	Intellectual developmental disorder, autosomal dominant 53	OMIM:617798
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Mitochondrial complex II deficiency, nuclear type 2	OMIM:619166
1275	0.4723	Mitochondrial complex II deficiency, nuclear type 4	OMIM:619224
1275	0.4723	Developmental and epileptic encephalopathy 31B, autosomal recessive	OMIM:620352
1275	0.4723	Childhood absence epilepsy	ORPHA:64280
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Parkinson disease 7, autosomal recessive early-onset	OMIM:606324
1275	0.4723	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	OMIM:613077
1275	0.4723	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
1275	0.4723	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
1275	0.4723	Wolfram-like syndrome, autosomal dominant	OMIM:614296
1275	0.4723	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
1275	0.4723	Intellectual developmental disorder, X-linked syndromic, Lubs type	OMIM:300260
1275	0.4723	Intellectual disability-severe speech delay-mild dysmorphism syndrome	ORPHA:391372
1275	0.4723	Lamb-Shaffer syndrome	OMIM:616803
1275	0.4723	Yunis-Varon syndrome	OMIM:216340
1275	0.4723	Hardikar syndrome	OMIM:301068
1275	0.4723	Ogden syndrome	OMIM:300855
1275	0.4723	Farber lipogranulomatosis	OMIM:228000
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	22q11.2 duplication syndrome	ORPHA:1727
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Childhood absence epilepsy	ORPHA:64280
1275	0.4723	GLUT1 deficiency syndrome 2, childhood onset	OMIM:612126
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Panic disorder, susceptibility to	OMIM:167870
1275	0.4723	Coffin-Siris syndrome 6	OMIM:617808
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Childhood absence epilepsy	ORPHA:64280
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1275	0.4723	3-hydroxyisobutryl-CoA hydrolase deficiency	OMIM:250620
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Salt and pepper developmental regression syndrome	OMIM:609056
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Infantile dystonia-parkinsonism	ORPHA:238455
1275	0.4723	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1275	0.4723	Parkinsonism with polyneuropathy	OMIM:619279
1275	0.4723	17p11.2 microduplication syndrome	ORPHA:1713
1275	0.4723	Developmental and epileptic encephalopathy 38	OMIM:617020
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Childhood absence epilepsy	ORPHA:64280
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Developmental and epileptic encephalopathy 41	OMIM:617105
1275	0.4723	Niemann-Pick disease, type A	OMIM:257200
1275	0.4723	Developmental and epileptic encephalopathy 44	OMIM:617132
1275	0.4723	Developmental and epileptic encephalopathy 56	OMIM:617665
1275	0.4723	Malan overgrowth syndrome	ORPHA:420179
1275	0.4723	Malan syndrome	OMIM:614753
1275	0.4723	Usher syndrome type 3	ORPHA:231183
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Intellectual developmental disorder with autism and macrocephaly	OMIM:615032
1275	0.4723	Neurodevelopmental disorder with or without seizures and gait abnormalities	OMIM:617864
1275	0.4723	Alazami syndrome	OMIM:615071
1275	0.4723	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	OMIM:616657
1275	0.4723	Intellectual developmental disorder, X-linked 12	OMIM:300957
1275	0.4723	Rickets, vitamin D-resistant, type IIA	OMIM:277440
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Mitochondrial DNA depletion syndrome 2 (myopathic type)	OMIM:609560
1275	0.4723	Alpha-mannosidosis, infantile form	ORPHA:309282
1275	0.4723	Alpha-mannosidosis, adult form	ORPHA:309288
1275	0.4723	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
1275	0.4723	Vitamin D-dependent rickets, type I	OMIM:264700
1275	0.4723	Liver disease, severe congenital	OMIM:619991
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Noonan syndrome-like disorder with loose anagen hair 2	OMIM:617506
1275	0.4723	Combined D-2- and L-2-hydroxyglutaric aciduria	OMIM:615182
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Severe Canavan disease	ORPHA:314911
1275	0.4723	Intellectual developmental disorder with autistic features and language delay, with or without seizures	OMIM:618906
1275	0.4723	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
1275	0.4723	Usher syndrome type 2	ORPHA:231178
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Fructose-1,6-bisphosphatase deficiency	ORPHA:348
1275	0.4723	Fructose-1,6-bisphosphatase deficiency	OMIM:229700
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	OMIM:617186
1275	0.4723	Acromegaly	ORPHA:963
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Ornithine transcarbamylase deficiency	OMIM:311250
1275	0.4723	Dravet syndrome	ORPHA:33069
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	White-Kernohan syndrome	OMIM:619426
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Xq25 microduplication syndrome	ORPHA:521258
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Asparagine synthetase deficiency	OMIM:615574
1275	0.4723	Pyridoxine-dependent epilepsy	ORPHA:3006
1275	0.4723	Severe X-linked mitochondrial encephalomyopathy	ORPHA:238329
1275	0.4723	Combined oxidative phosphorylation deficiency 6	OMIM:300816
1275	0.4723	Dyskinesia with orofacial involvement, autosomal dominant	OMIM:606703
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Intellectual developmental disorder, X-linked 63	OMIM:300387
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Citrullinemia	OMIM:215700
1275	0.4723	Aicardi-Goutieres syndrome 5	OMIM:612952
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)	OMIM:619425
1275	0.4723	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Pontocerebellar hypoplasia type 10	ORPHA:411493
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Gabriele-de Vries syndrome	OMIM:617557
1275	0.4723	Gabriele-de Vries syndrome	ORPHA:506358
1275	0.4723	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
1275	0.4723	Generalized arterial calcification of infancy	ORPHA:51608
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Pterin-4 alpha-carbinolamine dehydratase deficiency	ORPHA:1578
1275	0.4723	Non-syndromic posterior hypospadias	ORPHA:95706
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	OMIM:618092
1275	0.4723	Glycogen storage disease due to hepatic glycogen synthase deficiency	ORPHA:2089
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Developmental and epileptic encephalopathy 15	OMIM:615006
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Folate malabsorption, hereditary	OMIM:229050
1275	0.4723	Usher syndrome type 2	ORPHA:231178
1275	0.4723	Intellectual developmental disorder, autosomal dominant 45	OMIM:617600
1275	0.4723	Dystonia 26, myoclonic	OMIM:616398
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Usher syndrome type 2	ORPHA:231178
1275	0.4723	Usher syndrome type 2	ORPHA:231178
1275	0.4723	Neurodevelopmental disorder with spasticity and poor growth	OMIM:618076
1275	0.4723	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, encephalopathic type	OMIM:615228
1275	0.4723	Hereditary central diabetes insipidus	ORPHA:30925
1275	0.4723	Squalene synthase deficiency	OMIM:618156
1275	0.4723	Usher syndrome type 3	ORPHA:231183
1275	0.4723	Congenital heart defects, multiple types, 7	OMIM:618780
1275	0.4723	Carbamoylphosphate synthetase I deficiency	OMIM:237300
1275	0.4723	Carnitine-acylcarnitine translocase deficiency	OMIM:212138
1275	0.4723	Carnitine-acylcarnitine translocase deficiency	ORPHA:159
1275	0.4723	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	OMIM:612073
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Congenital disorder of glycosylation, type IIc	OMIM:266265
1275	0.4723	Argininosuccinic aciduria	OMIM:207900
1275	0.4723	?Leukodystrophy, hypomyelinating, 20	OMIM:619071
1275	0.4723	COG4-CDG	ORPHA:263501
1275	0.4723	Congenital disorder of glycosylation, type IIj	OMIM:613489
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Mitochondrial complex I deficiency, nuclear type 5	OMIM:618226
1275	0.4723	Rett syndrome, congenital variant	OMIM:613454
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Microcephaly, developmental delay, and brittle hair syndrome	OMIM:618891
1275	0.4723	Molybdenum cofactor deficiency B	OMIM:252160
1275	0.4723	Von Hippel-Lindau disease	ORPHA:892
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Childhood absence epilepsy	ORPHA:64280
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Pontocerebellar hypoplasia type 2D	OMIM:613811
1275	0.4723	Hypoglycemia of infancy, leucine-sensitive	OMIM:240800
1275	0.4723	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy	OMIM:614249
1275	0.4723	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Intellectual disability and myopathy syndrome	OMIM:619719
1275	0.4723	Usher syndrome type 3	ORPHA:231183
1275	0.4723	Pontocerebellar hypoplasia, type 2E	OMIM:615851
1275	0.4723	Beta-thalassemia major	ORPHA:231214
1275	0.4723	Dominant beta-thalassemia	ORPHA:231226
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	OMIM:615281
1275	0.4723	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures	OMIM:618725
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation	ORPHA:438216
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Intellectual developmental disorder with seizures and language delay	OMIM:619000
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	OMIM:616539
1275	0.4723	Mitochondrial complex I deficiency, nuclear type 13	OMIM:618235
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy	OMIM:619076
1275	0.4723	Cornelia de Lange syndrome	ORPHA:199
1275	0.4723	Diabetes insipidus, nephrogenic, 2	OMIM:125800
1275	0.4723	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
1275	0.4723	Hemophagocytic lymphohistiocytosis, familial, 2	OMIM:603553
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Pontocerebellar hypoplasia, type 9	OMIM:615809
1275	0.4723	Osteopetrosis, autosomal recessive 5	OMIM:259720
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Aicardi-Goutieres syndrome 7	OMIM:615846
1275	0.4723	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1275	0.4723	Systemic lupus erythematosus 17	OMIM:301080
1275	0.4723	Intellectual developmental disorder, autosomal recessive 73	OMIM:619717
1275	0.4723	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Usher syndrome type 3	ORPHA:231183
1275	0.4723	Acromegaly	ORPHA:963
1275	0.4723	Hypoparathyroidism, familial isolated 1	OMIM:146200
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Argininemia	OMIM:207800
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	?Leukodystrophy, childhood-onset, remitting	OMIM:619864
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Microcephaly, Amish type	OMIM:607196
1275	0.4723	Amish lethal microcephaly	ORPHA:99742
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Jansen-de Vries syndrome	OMIM:617450
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form	ORPHA:79351
1275	0.4723	Usher syndrome type 2	ORPHA:231178
1275	0.4723	Hypogonadotropic hypogonadism 26 with or without anosmia	OMIM:619718
1275	0.4723	Holocarboxylase synthetase deficiency	OMIM:253270
1275	0.4723	Holocarboxylase synthetase deficiency	ORPHA:79242
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	OMIM:617393
1275	0.4723	Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract	ORPHA:500545
1275	0.4723	Transcobalamin II deficiency	OMIM:275350
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Coproporphyria	OMIM:121300
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Atelis syndrome 2	OMIM:620185
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Kaya-Barakat-Masson syndrome	OMIM:619125
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	?Aicardi-Goutieres syndrome 8	OMIM:619486
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Pontocerebellar hypoplasia, type 1C	OMIM:616081
1275	0.4723	Childhood-onset spasticity with hyperglycinemia	ORPHA:401866
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Cone-rod synaptic disorder syndrome, congenital nonprogressive	OMIM:618970
1275	0.4723	ALG9-CDG	ORPHA:79328
1275	0.4723	Porphyria variegata	ORPHA:79473
1275	0.4723	Mitochondrial complex I deficiency, nuclear type 15	OMIM:618237
1275	0.4723	Beck-Fahrner syndrome	OMIM:618798
1275	0.4723	Generalized arterial calcification of infancy	ORPHA:51608
1275	0.4723	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	OMIM:607483
1275	0.4723	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	OMIM:618367
1275	0.4723	Rahman syndrome	OMIM:617537
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Neurodevelopmental disorder with dysmorphic facies and variable seizures	OMIM:619264
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Usher syndrome type 1	ORPHA:231169
1275	0.4723	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
1275	0.4723	Liver failure, transient infantile	OMIM:613070
1275	0.4723	Mitochondrial complex I deficiency, nuclear type 19	OMIM:618241
1275	0.4723	Intellectual developmental disorder, autosomal dominant 57	OMIM:618050
1275	0.4723	Developmental and epileptic encephalopathy 73	OMIM:618379
1275	0.4723	RNF13-related severe early-onset epileptic encephalopathy	ORPHA:544503
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Allan-Herndon-Dudley syndrome	OMIM:300523
1275	0.4723	Multiple mitochondrial dysfunctions syndrome 3	OMIM:615330
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Diabetes insipidus, nephrogenic, 1	OMIM:304800
1275	0.4723	Nephrogenic syndrome of inappropriate antidiuresis	OMIM:300539
1275	0.4723	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
1275	0.4723	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Pontocerebellar hypoplasia, type 2F	OMIM:617026
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency	ORPHA:404440
1275	0.4723	Joubert syndrome 14	OMIM:614424
1275	0.4723	Peroxisomal acyl-CoA oxidase deficiency	OMIM:264470
1275	0.4723	Aicardi-Goutieres syndrome 6	OMIM:615010
1275	0.4723	Aicardi-Goutières syndrome	ORPHA:51
1275	0.4723	Hypophosphatasia, infantile	OMIM:241500
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Von Hippel-Lindau disease	ORPHA:892
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Developmental and epileptic encephalopathy 49	OMIM:617281
1275	0.4723	Cystic fibrosis	ORPHA:586
1275	0.4723	?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome	OMIM:618878
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Neurodevelopmental disorder with eye movement abnormalities and ataxia	OMIM:620094
1275	0.4723	Fabry disease	ORPHA:324
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Leukodystrophy, hypomyelinating, 13	OMIM:616881
1275	0.4723	Celiac disease, susceptibility to	OMIM:212750
1275	0.4723	Developmental and epileptic encephalopathy 35	OMIM:616647
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	OMIM:620007
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Non-syndromic posterior hypospadias	ORPHA:95706
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	ORPHA:502423
1275	0.4723	Myopathy, mitochondrial, and ataxia	OMIM:617675
1275	0.4723	FINCA syndrome	OMIM:618278
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Pyridoxine-dependent epilepsy	ORPHA:3006
1275	0.4723	Epilepsy, early-onset, 1, vitamin B6-dependent	OMIM:617290
1275	0.4723	Renpenning syndrome	OMIM:309500
1275	0.4723	Neuroocular syndrome	OMIM:619539
1275	0.4723	Glycogen storage disease due to liver glycogen phosphorylase deficiency	ORPHA:369
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	22q11.2 deletion syndrome	ORPHA:567
1275	0.4723	Intellectual developmental disorder with neuropsychiatric features	OMIM:617532
1275	0.4723	Intellectual developmental disorder, X-linked syndromic 33	OMIM:300966
1275	0.4723	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Williams syndrome	ORPHA:904
1275	0.4723	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	OMIM:619685
1275	0.4723	McLeod syndrome with or without chronic granulomatous disease	OMIM:300842
1623	0.4312	Paragangliomas 4	OMIM:115310
1623	0.4312	Paragangliomas 1, with or without deafness	OMIM:168000
1623	0.4312	Paragangliomas 3	OMIM:605373
